Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
DiaMedica Therapeutics Inc. | Chief Business Officer | Voting Common Shares, no par value per share | 527K | $1.48M | $2.80 | Jun 1, 2024 | Direct |
DiaMedica Therapeutics Inc. | Chief Business Officer | Stock Option (right to buy) | 130K | Jun 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DMAC | DiaMedica Therapeutics Inc. | Jun 1, 2024 | 1 | $0 | 4 | Jun 3, 2024 | Chief Business Officer |
DMAC | DiaMedica Therapeutics Inc. | Nov 16, 2023 | 1 | $49.2K | 4 | Nov 16, 2023 | Chief Business Officer |
DMAC | DiaMedica Therapeutics Inc. | Jun 23, 2023 | 1 | $150K | 4 | Jun 26, 2023 | Chief Business Officer |
DMAC | DiaMedica Therapeutics Inc. | Apr 10, 2023 | 2 | $750K | 4 | Apr 11, 2023 | Chief Business Officer |
DMAC | DiaMedica Therapeutics Inc. | Apr 10, 2023 | 0 | $0 | 3 | Apr 11, 2023 | Chief Business Officer |